The bonuses, which will be given for financial performance, were voted on by trustees and come after Erlanger froze employees’ vacation time and warned of financial crisis earlier this year, according to the report.
But the report states the bonuses are possible because Erlanger was able to change things around, thanks largely to $19 million in federal funds via the Public Hospital Supplemental Payment Pool.
The average bonus size will be $17,100, with Erlanger CEO Kevin Spiegel collecting $234,669 in bonus pay, according to the report.
According to the report, trustees also gave the go-ahead for Mr. Spiegel to receive a 10 percent raise next year, and approved a 2 percent nonbudgeted pay raise for hospital employees.
“Management has performed exceedingly well,” Chairman Donnie Hutcherson said in the report. “This is well deserved. They have put in long, long hours.”
But board member Gerald Webb, who, according to the report, voted against the bonus payments, as well as changes to Mr. Spiegel’s contract, told the Chattanooga Times Free Press, “Erlanger has had financial issues for a while. For the first time we’re seeing positive numbers. My thinking is that more of a percentage of that money needs to go to into reserves or to employees, instead of vice presidents and executives. I had to vote my conscience.”
More articles on Erlanger:
Erlanger Health employees unhappy with disarming security guards
Fitch assigns ‘BBB’ rating to Erlanger Health System’s bonds
Erlanger Health System Board Approves Affiliation Agreement With UT
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
